reports
- GlobalData Healthcare Department
TWi Pharmaceuticals Inc (4180) - Financial Analysis Review
TWi Pharmaceuticals Inc (4180) - Financial Analysis Review Summary TWi Pharmaceuticals Inc (TWi), formerly Anchen Pharmaceuticals (Taiwan) Inc is a manufacturer of high barrier generics drugs. The company’s products include donepezil hydrochloride tablets, hydroquinone cream, hydroquinone time release cream, megestrol acetate oral suspension and nifedipine extended-release tablets. Its drugs consists of oral controlled release dosage form, non-oral parental and transdermal products, novel dr...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.